Pharmaceutical Resources

Life sciences leaders like you must address changes and pressures along the pharmaceutical value chain. That’s why life sciences market experts from Optum® and Advisory Board came together once again to offer their take on 6 trends shaping pharmaceutical manufacturer strategies in 2024. Watch the on-demand webinar now.

The American Society of Clinical Oncology (ASCO) Annual Meeting ranks as one of the largest and most impactful oncology conferences. The content published during the annual meeting can change established practices, and many of the trends identified reflect the current or future industry landscape in oncology.

Specialty pharmacies must adapt to drug pipeline and market shifts. This white paper presents 3 insights on future changes in specialty pharmacy models, including refining operations, pursuing value-based partnerships, and enhancing their value proposition. Access the full white paper for details.

When it comes to reducing risk and elevating decision-making in drug development, artificial intelligence (AI) is one of the tools to transform both.

It is difficult to find one person who has not heard of the “opioid crisis,” referring to outpatients becoming addicted to opiates after being prescribed for various reasons. Learn how to prevent hospitalization-related iatrogenic dependence and reduce hospital return rates among older patients in this article.

In an August 2022 market research study, more than 600 medical science liaisons (MSLs) weighed in on virtual vs in-person engagements with potential key opinion leaders (KOLs); how it impacted their day-to day work and why even with more digital tools available.

Drugs used to treat ADHD have been lacking for months now, leading to problems with access to prescription amphetamines and creating questions about the cause of the massive shortage. Download the article to know more.

With it being reported that 84% of the American population is covered by prescription drug insurance, it has become critical for organizations to prioritize drug management and other customer interactions. So, how can companies combat new issues and set themselves up for success? Dig into this guide to learn more.

Leading life sciences organizations like Moderna, AstraZeneca, and Thermo Fisher Scientific leverage AWS to remove the undifferentiated heavy lifting to focus more time and resources on bringing new and differentiated treatments to market. Read this eBook to learn how you can do the same.

Under traditional supply chain scenarios, physicians have little visibility into the volume and cost of the products and devices they consume. Read this paper to understand how a digitized supply chain creates clearer consumption visibility, supports better patient outcomes, and reduces waste and expense.